A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor - PubMed (original) (raw)

A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor

C Ponzetto et al. Mol Cell Biol. 1993 Aug.

Abstract

The pleiotropic effects (mitogenesis, motogenesis, and morphogenesis) elicited by hepatocyte growth factor/scatter factor (HGF/SF) are mediated by the activation of the tyrosine kinase receptor encoded by the MET proto-oncogene. Following autophosphorylation, the receptor associates with the p85/110 phosphatidylinositol (PI) 3-kinase complex in vivo and in vitro. By a combination of two complementary approaches, competition with synthetic phosphopeptides and association with Tyr-Phe receptor mutants, we have identified Y-1349 and Y-1356 in the HGF/SF receptor as the binding sites for PI 3-kinase. Y-1349VHV and Y-1356VNV do not conform to the canonical consensus sequence YXXM for PI 3-kinase binding and thus define YVXV as a novel recognition motif. Y-1349 and Y-1356 are located within the C-terminal portion of the HGF/SF receptor and are phosphorylation sites. The affinity of the N- and C-terminal src homology region 2 (SH2) domains of p85 for the phosphopeptides including Y-1349 and Y-1356 is 2 orders of magnitude lower than that measured for Y-751 in the platelet-derived growth factor receptor binding site. However, the closely spaced duplication of the novel recognition motif in the native HGF/SF receptor may allow binding with both SH2 domains of p85, thus generating an efficient docking site for PI 3-kinase. In agreement with this model, we have observed that a phosphopeptide including both Y-1349 and Y-1356 activates PI 3-kinase in vitro.

PubMed Disclaimer

Similar articles

• A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.
  Hartmann G, Naldini L, Weidner KM, Sachs M, Vigna E, Comoglio PM, Birchmeier W. Hartmann G, et al. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11574-8. doi: 10.1073/pnas.89.23.11574. Proc Natl Acad Sci U S A. 1992. PMID: 1280830 Free PMC article.
• Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains.
  Bardelli A, Maina F, Gout I, Fry MJ, Waterfield MD, Comoglio PM, Ponzetto C. Bardelli A, et al. Oncogene. 1992 Oct;7(10):1973-8. Oncogene. 1992. PMID: 1328986
• The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.
  Weidner KM, Sachs M, Birchmeier W. Weidner KM, et al. J Cell Biol. 1993 Apr;121(1):145-54. doi: 10.1083/jcb.121.1.145. J Cell Biol. 1993. PMID: 8384622 Free PMC article.
• Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.
  Bardelli A, Ponzetto C, Comoglio PM. Bardelli A, et al. J Biotechnol. 1994 Sep 30;37(2):109-22. doi: 10.1016/0168-1656(94)90002-7. J Biotechnol. 1994. PMID: 7765452 Review.

Cited by

• A novel role for Bruton's tyrosine kinase in hepatocyte growth factor-mediated immunoregulation of dendritic cells.
  Singhal E, Kumar P, Sen P. Singhal E, et al. J Biol Chem. 2011 Sep 16;286(37):32054-63. doi: 10.1074/jbc.M111.271247. Epub 2011 Jul 22. J Biol Chem. 2011. PMID: 21784852 Free PMC article.
• Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis.
  Jeffers M, Rong S, Vande Woude GF. Jeffers M, et al. J Mol Med (Berl). 1996 Sep;74(9):505-13. doi: 10.1007/BF00204976. J Mol Med (Berl). 1996. PMID: 8892055 Review.
• The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.
  Tulasne D, Paumelle R, Weidner KM, Vandenbunder B, Fafeur V. Tulasne D, et al. Mol Biol Cell. 1999 Mar;10(3):551-65. doi: 10.1091/mbc.10.3.551. Mol Biol Cell. 1999. PMID: 10069803 Free PMC article.
• Physiological Signaling and Structure of the HGF Receptor MET.
  Baldanzi G, Graziani A. Baldanzi G, et al. Biomedicines. 2014 Dec 31;3(1):1-31. doi: 10.3390/biomedicines3010001. Biomedicines. 2014. PMID: 28536396 Free PMC article. Review.
• HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment.
  Hartmann S, Bhola NE, Grandis JR. Hartmann S, et al. Clin Cancer Res. 2016 Aug 15;22(16):4005-13. doi: 10.1158/1078-0432.CCR-16-0951. Epub 2016 Jul 1. Clin Cancer Res. 2016. PMID: 27370607 Free PMC article. Review.

References

1. 1. Gene. 1988 Jul 15;67(1):31-40 - PubMed
2. 1. Mol Cell Biol. 1991 Oct;11(10):5068-78 - PubMed
3. 1. EMBO J. 1991 Oct;10(10):2867-78 - PubMed
4. 1. Oncogene. 1991 Apr;6(4):553-9 - PubMed
5. 1. Mol Cell Biol. 1990 Nov;10(11):5601-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • GlyGen glycoinformatics resource
  • PhosphoSitePlus

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal